Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CME GROUP INC. Director's Dealing 2020

Mar 17, 2020

29871_dirs_2020-03-17_2d2a8f6d-2b33-41ee-a792-3f3b46cb96d6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2020-03-15

Reporting Person: CRONIN KATHLEEN M (Sr MD Gen Counsel & Corp Secr)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-03-15 Common Stock Class A A 4804 $0.0 Acquired 46360 Direct
2020-03-15 Common Stock Class A F 1734 $182.01 Disposed 44626 Direct
2020-03-15 Common Stock Class A A 4804 $0.0 Acquired 49430 Direct
2020-03-15 Common Stock Class A F 2129 $182.01 Disposed 47301 Direct

Footnotes

F1: Represents shares earned from a 2016 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2017-2019.

F2: Ms. Cronin surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award.